StockData
HCW Biologics Inc. logo

HCW Biologics Inc. (HCWB) stock

HCWBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3095% below fair value
$0.76−0.01 (-1.65%)

Close on Nov 18, 2026Market cap $1.40MP/E –Yield –

HCW Biologics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

HCW Biologics's price to sales ratio was 0.1× on Nov 11, 2026, against 7.8× a year earlier. Over the last 5 years it ranged from 0.1× to 24.6×, with a median of 7.6×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.1×−3.5
2025Dec 31, 20253.6×−1.2
2024Dec 31, 20244.7×−10.6
2023Dec 29, 202315.4×+2.6
2022Dec 30, 202212.7×+6.5
2021Dec 31, 20216.2×–

More HCW Biologics figures

See a number that looks wrong?